MK5, also known as MAPKAPK5, has recently been shown to be a positive regulator of YAP in both mesothelioma and uveal melanoma, by its association with YAP preventing CK1δ/ε-mediated proteasomal degradation. Here, YAP1 is linked to uveal melanoma.